HOYA Corporation

Life Care demand is structurally recurring, driven by prescription renewals, cataract surgeries, and hospital endoscopy procedures tied to aging-population demographics rather than economic cycles. The Information Technology segment is linked to chipmaker node transitions and fab build schedules, introducing volume variability that prevents the combined business from achieving subscription-like forward visibility.

Life Care accounts for approximately 64% of consolidated FY2025 revenue and IT for roughly 36%, and the two segments address uncorrelated demand cycles. Concentration within Life Care in ophthalmic lenses, and within IT in photomask blanks, limits the diversification benefit of the two-segment structure.

Asia and Oceania accounted for approximately 69.5% of FY2025 revenue, driven by semiconductor customers concentrated in East Asia and optical lens distribution across the region. Europe (12.3%), the Americas (9.1%), and Japan (9.1%) comprise the remainder, with no region outside Asia approaching meaningful scale.

HOYA's Information Technology segment generates the majority of group profit despite representing roughly 36% of consolidated revenue, reflecting high incremental margins on photomask blank production as semiconductor content per advanced node rises. ROIC has exceeded 48% in recent reported fiscal years, indicating strong returns on the capital deployed in both segments.

Both segments supply mission-critical products with limited substitutability: ophthalmic lenses and IOLs selected by name by patients and surgeons, and photomask blanks for which HOYA holds advanced-node specifications no other supplier can match. Revenue is not primarily contractual or subscription-based, but its defensive repeat-purchase nature in Life Care and structural necessity in IT places it clearly above average in quality.